Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples